Barely Significant
← all excerpts

The impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer.

Ann Med · 2025 · PMC12683747 · PMID 41346024

1
hedged sentence
0.4880
closest p · 9.8× alpha
0.4880
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.